101 related articles for article (PubMed ID: 17539800)
1. Latanoprost-related transient incontinence.
Raja V; Sandanshiv P; Asghar M; Moriarty B
Clin Exp Ophthalmol; 2007; 35(4):389-90. PubMed ID: 17539800
[TBL] [Abstract][Full Text] [Related]
2. Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma.
Nakamura Y; Nakamura Y; Morine-Shinjo S; Sakai H; Sawaguchi S
Acta Ophthalmol Scand; 2004 Apr; 82(2):158-60. PubMed ID: 15043533
[TBL] [Abstract][Full Text] [Related]
3. Transient monocular visual loss following administration of topical latanoprost: a case report.
Luu ST; Lee AW; Chen CS
Can J Ophthalmol; 2009 Dec; 44(6):715. PubMed ID: 20029498
[No Abstract] [Full Text] [Related]
4. Ocular complications of latanoprost in uveitic glaucoma: three case reports.
Saccà S; Pascotto A; Siniscalchi C; Rolando M
J Ocul Pharmacol Ther; 2001 Apr; 17(2):107-13. PubMed ID: 11324978
[TBL] [Abstract][Full Text] [Related]
5. Side effects associated with prostaglandin analog therapy.
Alm A; Grierson I; Shields MB
Surv Ophthalmol; 2008 Nov; 53 Suppl1():S93-105. PubMed ID: 19038628
[TBL] [Abstract][Full Text] [Related]
6. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
Chou SY; Chou CK; Kuang TM; Hsu WM
Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
[TBL] [Abstract][Full Text] [Related]
7. Eyelid hypertrichosis associated with latanoprost is reversible.
O'Toole L; Cahill M; O'Brien C
Eur J Ophthalmol; 2001; 11(4):377-9. PubMed ID: 11820311
[TBL] [Abstract][Full Text] [Related]
8. Migraine headache associated with latanoprost.
Weston BC
Arch Ophthalmol; 2001 Feb; 119(2):300-1. PubMed ID: 11176999
[No Abstract] [Full Text] [Related]
9. Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost.
Herndon LW; Asrani SG; Williams GH; Challa P; Lee PP
Arch Ophthalmol; 2002 Jun; 120(6):847-9. PubMed ID: 12049597
[No Abstract] [Full Text] [Related]
10. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
11. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma.
Alm A; Schoenfelder J; McDermott J
Arch Ophthalmol; 2004 Jul; 122(7):957-65. PubMed ID: 15249358
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the additive effect of bunazosin on latanoprost in primary open-angle glaucoma.
Maruyama K; Shirato S; Haneda M
Jpn J Ophthalmol; 2005; 49(1):61-2. PubMed ID: 15692779
[No Abstract] [Full Text] [Related]
13. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect.
Kobayashi H; Kobayashi K
J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573
[TBL] [Abstract][Full Text] [Related]
14. Severe darkening of a facial skin graft from latanoprost.
Calladine D; Harrison RJ
Arch Ophthalmol; 2007 Oct; 125(10):1427-8. PubMed ID: 17923558
[No Abstract] [Full Text] [Related]
15. A case of keratoconus progression associated with the use of topical latanoprost.
Amano S; Nakai Y; Ko A; Inoue K; Wakakura M
Jpn J Ophthalmol; 2008; 52(4):334-336. PubMed ID: 18773275
[No Abstract] [Full Text] [Related]
16. Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report.
Tsai JC; Sivak-Callcott JA; Haik BG; Zhang J; McLean IW
J Glaucoma; 2001 Oct; 10(5):411-3. PubMed ID: 11711840
[TBL] [Abstract][Full Text] [Related]
17. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
18. Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study.
Stecchi G; Saccucci S; Molinari S; De Gregorio F
Acta Ophthalmol Scand Suppl; 2002; 236():56-7. PubMed ID: 12390146
[No Abstract] [Full Text] [Related]
19. Eyelash hypertrichosis in a patient treated with topical latanoprost.
Strober BE; Potash S; Grossman ME
Cutis; 2001 Feb; 67(2):109-10. PubMed ID: 11236218
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension.
Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
Br J Ophthalmol; 2013 Dec; 97(12):1510-5. PubMed ID: 23681371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
